Our top pick for
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Medigard is a medical instruments & supplies business based in Australia. Medigard shares (MGZ) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollar. Medigard has a trailing 12-month revenue of around $623,740. If you're looking to buy shares, check out the steps below.
|52-week range||$0.02 - $0.02|
|50-day moving average||$0.02|
|200-day moving average||$0.02|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.002|
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Medigard stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medigard 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medigard 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Medigard shares trade at around 10x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Medigard 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $278,509 (£145,433).
The EBITDA is a measure of a Medigard 's overall financial performance and is widely used to measure a its profitability.
|Gross profit TTM||$-150,000|
|Return on assets TTM||-318.93%|
|Return on equity TTM||0%|
|Market capitalisation||$2.7 million|
TTM: trailing 12 months
We're not expecting Medigard to pay a dividend over the next 12 months.
Over the last 12 months, Medigard 's shares have ranged in value from as little as $0.02 up to $0.02. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Medigard 's is 0.3878. This would suggest that Medigard 's shares are less volatile than average (for this exchange).
Medigard Limited operates as a life sciences company in Australia. The company researches and develops medical technologies, including KT009 project to treat degenerative disk disease with an injectable product. Medigard Limited was founded in 1999 and is based in Main Beach, Australia.
With the IRS and SEC addressing Ethereum in a negative light recently, it appears as though the altcoin may potentially be faced with increased turbulence in the near term.
With the Fed looking to initiate its long withstanding tapering plans within the next month or so, volatility across markets (including stocks and crypto) is expected to increase.
Don’t miss out on this gargantuan list of incredible titles.
We got our hands on the new Charlotte Tilbury Beautiful Skin foundation and here are our thoughts on the $60 product.
The Jabra PanaCast 20 is a cracker of a webcam that will quite literally follow you wherever you go. But it has a price tag that’s hard to get past.
It's important to be positive about the year ahead and start thinking about how to make 2022 your most fulfilling yet.
Book flexible flights now to Fiji, New Zealand, Singapore, Japan, USA, UK and more.
The 10 biggest movers on the ASX for Friday 28 January 2022.
finder.com.au is one of Australia's leading comparison websites. We compare from a wide set of banks, insurers and product issuers. We value our editorial independence and follow editorial guidelines.
finder.com.au has access to track details from the product issuers listed on our sites. Although we provide information on the products offered by a wide range of issuers, we don't cover every available product or service.
Please note that the information published on our site should not be construed as personal advice and does not consider your personal needs and circumstances. While our site will provide you with factual information and general advice to help you make better decisions, it isn't a substitute for professional advice. You should consider whether the products or services featured on our site are appropriate for your needs. If you're unsure about anything, seek professional advice before you apply for any product or commit to any plan.
Products marked as 'Promoted' or 'Advertisement' are prominently displayed either as a result of a commercial advertising arrangement or to highlight a particular product, provider or feature. Finder may receive remuneration from the Provider if you click on the related link, purchase or enquire about the product. Finder's decision to show a 'promoted' product is neither a recommendation that the product is appropriate for you nor an indication that the product is the best in its category. We encourage you to use the tools and information we provide to compare your options.
Where our site links to particular products or displays 'Go to site' buttons, we may receive a commission, referral fee or payment when you click on those buttons or apply for a product. You can learn more about how we make money here.
When products are grouped in a table or list, the order in which they are initially sorted may be influenced by a range of factors including price, fees and discounts; commercial partnerships; product features; and brand popularity. We provide tools so you can sort and filter these lists to highlight features that matter to you.
We try to take an open and transparent approach and provide a broad-based comparison service. However, you should be aware that while we are an independently owned service, our comparison service does not include all providers or all products available in the market.
Some product issuers may provide products or offer services through multiple brands, associated companies or different labelling arrangements. This can make it difficult for consumers to compare alternatives or identify the companies behind the products. However, we aim to provide information to enable consumers to understand these issues.
Providing or obtaining an estimated insurance quote through us does not guarantee you can get the insurance. Acceptance by insurance companies is based on things like occupation, health and lifestyle. By providing you with the ability to apply for a credit card or loan, we are not guaranteeing that your application will be approved. Your application for credit products is subject to the Provider's terms and conditions as well as their application and lending criteria.